CSO & Co-Founder
Liisi holds a PhD from Imperial College London in Computational Systems Biology, focusing on the transformation of low-grade gliomas to high-grade tumours and identifying genetic vulnerabilities in glioblastoma. At Karolinska Institute, she studied neuroscience, concentrating on the epigenetics of neural stemness. During her medical science studies at Uppsala University, where she ranked first in her class, she researched brain tumour microenvironments and vasculature. Liisi graduated cum laude from the University of Tartu, conducting research in human genetics and metabolomics. Liisi has been awarded multiple scholarships, including the highly competitive Imperial College President’s scholarship. Liisi is driven by the intricate complexity of biology and is passionate about leveraging systems biology to bridge preclinical discoveries and patient benefit.